Fungal Genomics & Biology
Open Access

Mycoses as a Public Health and Environmental Concern

Lara Fischer^{* *}Correspondence: Lara Fischer, Department of Mycology, University of Heidelberg, Germany, Email:

Author info »

Description

Fungal infections, collectively referred to as mycoses, represent a growing concern in human and animal health worldwide. Once considered rare and mostly opportunistic, mycoses have emerged as significant contributors to morbidity and mortality, particularly in immunocompromised populations. Advances in medicine, including organ transplantation, cancer therapies and widespread use of immunosuppressive drugs, have inadvertently increased susceptibility to fungal pathogens. While bacterial and viral infections often dominate public attention, fungal diseases demand equal scrutiny due to their adaptability, resistance potential and complex pathophysiology. One of the defining characteristics of mycoses is the opportunistic nature of many causative fungi. Species such as Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans frequently colonize healthy hosts without causing disease but can rapidly become pathogenic in immunocompromised individuals. This dual nature complicates diagnosis and treatment, as asymptomatic colonization may precede invasive infections. Moreover, the spectrum of mycoses extends beyond superficial infections to systemic and life threatening conditions, including candidemia, invasive aspergillosis and cryptococcal meningitis. These infections are particularly lethal in patients with weakened immunity, such as those living with HIV/AIDS or undergoing chemotherapy.

A major concern in the management of mycoses is the growing issue of antifungal resistance. Unlike bacteria, fungi are eukaryotic organisms, sharing many cellular features with their hosts. This similarity limits the number of selective drug targets, resulting in a relatively small arsenal of antifungal agents. The main classes azoles, echinocandins and polyenes target fungal cell membranes or cell walls, yet resistance is increasingly reported. Mechanisms of resistance include point mutations in drug targets, overexpression of efflux pumps, biofilm formation and adaptive metabolic changes. Combating resistance requires innovative approaches, including combination therapies, development of new drug classes and stewardship programs to optimize antifungal use. Beyond human health, mycoses have profound implications for agriculture, livestock and global food security. Plant pathogenic fungi, such as Fusarium, Magnaporthe and Botrytis species, inflict substantial economic losses by reducing crop yield and quality. The reliance on chemical fungicides to control these pathogens can lead to environmental contamination, non target species effects and emergence of resistant fungal strains. Similarly, fungi affecting livestock, poultry and aquaculture systems threaten animal health, productivity and welfare. Recent advances in genomics, transcriptomics and proteomics have transformed our understanding of mycoses. Sequencing technologies enable rapid identification of fungal species and their genetic determinants of virulence and resistance. Functional genomics approaches, including RNA sequencing and proteomic profiling, reveal fungal adaptation to host environments, stress responses and metabolic strategies essential for pathogenicity. For plant pathogens, identification of effector proteins has elucidated mechanisms of host, guiding the development of resistant crop varieties. In human medicine, these insights inform novel diagnostics, vaccine development and targeted antifungal therapies.

Despite their significance, mycoses remain under recognized in public health discourse. Limited awareness, insufficient surveillance and underfunded research initiatives impede timely identification and management of emerging fungal threats. Climate change and global travel exacerbate this problem by altering fungal ecology, geographic distribution and virulence. The emergence of Candida auris, a multidrug resistant pathogen capable of rapid global spread, illustrates the potential consequences of these environmental and epidemiological changes. Preparing for fungal threats requires interdisciplinary collaboration across microbiology, immunology, genomics, ecology and public health. Several strategies offer promise in addressing the growing of mycoses. Host directed therapies that enhance immune responses could complement traditional antifungal drugs, especially in immunocompromised patients. Microbiome modulation presents another opportunity, as a balanced microbial ecosystem can prevent fungal overgrowth and infection. In agricultural systems, precision farming techniques and biologically based control measures may reduce dependence on chemical fungicides while managing plant pathogenic fungi sustainably. Finally, global initiatives that promote data sharing, genomic surveillance and monitoring of resistance patterns are essential for anticipating and mitigating emerging threats.